Stockscreener 앱 받기
15.07
1.82%
0.27
시간 외 거래:
14.97
-0.10
-0.66%
전일 마감가:
$14.80
열려 있는:
$14.99
하루 거래량:
258.29K
Relative Volume:
0.03
시가총액:
$1.29M
수익:
$8.97M
순이익/손실:
$-15.21M
주가수익비율:
-0.1293
EPS:
-116.51
순현금흐름:
$-10.84M
1주 성능:
+92.96%
1개월 성능:
+5,540%
6개월 성능:
+1,188%
1년 성능:
+296.58%
1일 변동 폭
$14.38
$15.87
1주일 범위
$6.35
$25.95
52주 변동 폭
$0.19
$25.95
Nuwellis Inc Stock (NUWE) Company Profile
명칭
Nuwellis Inc
전화
952-345-4200
주소
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
NUWE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
15.07 | 1.29M | 8.97M | -15.21M | -10.84M | -116.51 |
|
ABT
Abbott Laboratories
|
124.42 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.78 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.32 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.70 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.56 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-29 | 개시 | ROTH MKM | Buy |
Nuwellis Inc 주식(NUWE)의 최신 뉴스
Is Nuwellis Inc. a good long term investmentDynamic investment opportunities - Autocar Professional
What drives Nuwellis Inc. stock priceRapid-fire capital growth - jammulinksnews.com
What analysts say about Nuwellis Inc. stockExplosive trading growth - jammulinksnews.com
Nuwellis Stock Rises After Hours Following Patent Win For Blood Filtering System — Retail Mood Turns Buoyant - MSN
Nuwellis Terminates REVERSE-HF Trial, Shifts Focus to Outpatient Heart Failure Care and Pediatric Markets - AInvest
Nuwellis Ends REVERSE-HF Trial to Focus on Growth Areas, Saves $4 Million - AInvest
Nuwellis Inc. Stock Analysis and ForecastSuperior stock selection - jammulinksnews.com
Nuwellis ends clinical trial of its ultrafiltration tech for heart failure - MassDevice
Medical Stocks To Add to Your Watchlist – July 16th - Defense World
Nuwellis stock falls after company terminates REVERSE-HF clinical trial - Investing.com
Nuwellis' New U.S. Patent and Market Implications: A Game-Changer in Fluid Management and a Long-Term Growth Catalyst for Investors - AInvest
Nuwellis terminates REVERSE-HF trial to focus on outpatient heart failure care - TipRanks
Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care - The Manila Times
Nuwellis, Inc. Terminates REVERSE-HF Clinical Trial to Focus on Outpatient Market Opportunities - Nasdaq
Nuwellis Pivots from REVERSE-HF Trial: Strategic $4M Shift to Outpatient Heart Failure Care Revealed - Stock Titan
Nuwellis Plunges 11.29% After Patent Surge - AInvest
Biotech And Crypto Moves Set Off Trading Frenzy - Finimize
Nuwellis Surges to 137th in Market Rankings with $703 Million Trading Volume - AInvest
Nuwellis appoints John Erb as CEO - MSN
Nuwellis Secures Patent Leadership in CRRT: A Breakthrough in Fluid Management for Critical Care - AInvest
Medical Stocks To Add to Your WatchlistJuly 16th - MarketBeat
Nuwellis' Patent Breakthrough: Can Fluid Management Innovation Sustain Momentum? - AInvest
Nuwellis (NUWE) Stock Skyrockets On New Patent: What's Going On? - Benzinga
Markets Inch Up As Lower Oil Prices And Flat Inflation Stand Out - Finimize
Why Nuwellis Shares Are Exploding Today: A 200% Surge Explained - Investing.com
Nuwellis shares surge 26.71% intraday after receiving a new U.S. patent on fluid management. - AInvest
Why are NUWE Shares Surging in Premarket Trading Today? - Tokenist
NUWE Stock Soars: Will It Last? - timothysykes.com
Why Is Nuwellis Stock (NUWE) Up 140% Today? - TipRanks
Nuwellis Shares Skyrocket 127.7% on Patent Win, Earnings - AInvest
Nuwellis shares jump 10.16% premarket after securing new U.S. patent on fluid management. - AInvest
Nuwellis' Fluid Management Patent: A Strategic Leap Forward, But Can It Stem the Tide? - AInvest
Nuwellis Soars 63.16% on New Patent, Earnings - AInvest
Nuwellis Stock Rises After Hours Following Patent Win For Blood Filtering SystemRetail Mood Turns Buoyant - Menafn.com
Nuwellis stock surges after securing key fluid management patent By Investing.com - Investing.com Nigeria
Nuwellis Receives US Patent on Fluid Management; Shares Rise After-hours - MarketScreener
Nuwellis stock surges after securing key fluid management patent - Investing.com
Nuwellis receives patent for improved blood filtering technology By Investing.com - Investing.com Canada
Nuwellis receives patent for improved blood filtering technology - Investing.com Australia
Nuwellis issued patent by USPTO - TipRanks
Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation - The Manila Times
Nuwellis, Inc. Secures U.S. Patent No. 12,357,734 for Innovative Blood Filtering System in Ultrafiltration Therapy - Nasdaq
Revolutionary Blood Filtering Patent Positions Nuwellis to Transform CRRT Accuracy - Stock Titan
What makes Nuwellis Inc. stock price move sharplySmart Growth Low Risk Picks - Newser
Why Nuwellis Inc. stock attracts strong analyst attentionHigh Confidence Trade Setups - Newser
Nuwellis Inc (NUWE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.15%
0.17%
자본화:
|
볼륨(24시간):